Interleukin 27 (IL27) Peptide
Quick Overview for Interleukin 27 (IL27) Peptide (ABIN936845)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- AQVSWPQLLS TYRLLHSLEL VLSRAVRELL LLSKAGHSVW PLGFPTLSPQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of IL27 antibody,
Alternative Names: IL27 control peptide, IL27 antibody Blocking Peptide, Anti-IL27 Blocking Peptide, interleukin 27 Blocking Peptide, IL-27 Blocking Peptide, IL-27A Blocking Peptide, IL27p28 Blocking Peptide, IL30 Blocking Peptide, MGC71873 Blocking Peptide, p28 Blocking Peptide, IL27, IL-27, IL 27, IL-27 Blocking Peptide, IL 27 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- IL-27 (IL27) (Interleukin 27 (IL27))
-
Background
- The protein encoded by this gene is one of the subunits of a heterodimeric cytokine complex. This protein is related to interleukin 12A (IL12A). It interacts with Epstein-Barr virus induced gene 3 (EBI3), a protein similar to interleukin 12B (IL12B), and forms a complex that has been shown to drive rapid expansion of naive but not memory CD4(+) T cells. The complex is also found to synergize strongly with interleukin 12 to trigger interferon gamma (IFNG) production of naive CD4(+) T cells. The biological effects of this cytokine are mediated by the class I cytokine receptor (WSX1/TCRR).
-
Molecular Weight
- 27 kDa
Target
-